Back to search

Article

Multi-omics investigation on the prognostic and predictive factors in metastatic breast cancer using data from Phase III ribociclib clinical trials: A statistical and machine learning analysis plan

2023-08-31

Abstract excerpt

<h4>A bstract </h4> In 2020, Novartis Pharmaceuticals Corporation and the U.S. Food and Drug Administration (FDA) started a 4-year scientific collaboration to find novel radiogenomics-based prognostic and predictive factors for HR+/HER2-metastatic breast cancer under a Research Collaboration Agreement. This manuscript aims to detail the guiding principles and methodology for this study. We include a discussion of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8ae37830-3185-5100-a18a-6d76e2c496a7
DOI
10.1101/2023.08.30.23294367
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Multi-omics investigation on the prognostic and predictive factors in metastatic breast cancer using data from Phase III ribociclib clinical trials: A statistical and machine learning analysis planDOI 10.1101/2023.08.30.23294367
Beyond Imaging: Integrating Radiomics, Genomics, and Multi-Omics for Precision Breast Cancer ManagementSemantic proximity
Multiomics insights on the onset, progression, and metastatic evolution of breast cancerSemantic proximity
Epigenetic profile drives accurate survival prediction in breast cancer via a multi-omics machine learning modelSemantic proximity
Epigenetic profile drives accurate survival prediction in breast cancer via a multi-omics machine learning modelSemantic proximity
Machine learning prediction of pathological complete response and overall survival of breast cancer patients in an underserved inner-city populationSemantic proximity
Prediction of clinical phenotypes in invasive breast carcinomas from the integration of radiomics and genomics dataSemantic proximity
ImaGene: A web-based software platform for tumor radiogenomic evaluation and reportingSemantic proximity
An Omic and Multidimensional Spatial Atlas from Serial Biopsies of an Evolving Metastatic Breast CancerSemantic proximity
Prognostic and predictive biomarkers with therapeutic targets in breast cancer: A 2022 update on current developments, evidence, and recommendationsSemantic proximity
AI‐Driven Multi‐Omics Integrated Applications Using Diverse Neural Networks for Breast Cancer Diagnostic Screening and Biomarker DiscoverySemantic proximity
Retrospective multi-cohort validation of a real-world transcriptomics-guided machine learning model for treatment response prediction in breast cancerSemantic proximity
Radiogenomic Analysis of Oncological Data: A Technical SurveySemantic proximity
Select a neighboring publication to make it the new centre.